Mri Interventions (MRIC) 0.6100 $MRIC MRI Interventions,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mri Interventions (MRIC) 0.6100 $MRIC

MRI Interventions, Inc. Announces 2015 Third Quarter Revenues
GlobeNewswire - Thu Oct 01, 6:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced its revenues for the third quarter and nine months ended September 30, 2015.

MRI Interventions wins National Institutes of Health Phase II grant for developing MRI-safe Myocardial Biopsy Forceps
M2 - Wed Sep 23, 5:12AM CDT
MRI instruments company MRI Interventions (OTCBB:MRIC) revealed on Tuesday the receipt of the Phase II grant award from the National Institutes of Health (NIH) for the development of clinical grade, MRI-safe Myocardial Biopsy Forceps.

MRI Interventions Announces Award of National Institutes of Health Phase II Grant
GlobeNewswire - Tue Sep 22, 7:30AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that it has received a Phase II grant award from the National Institutes of Health (NIH) for the development of clinical grade, MRI-safe Myocardial Biopsy Forceps. The Company previously completed a Phase I grant for the initial development phase of this technology, and will now enter the next phase of development.

MRI Interventions to Exhibit Its ClearPoint(R) Neuro Navigation System for Neurosurgery at CNS 2015 Annual Meeting
GlobeNewswire - Tue Sep 15, 7:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System will be on exhibit at the Congress of Neurological Surgeons (CNS) 2015 Annual Meeting September 26 - 30, 2015, in New Orleans, LA and will also be featured in the Innovations Showcase. CNS attendees are invited to visit the MRI Interventions booth (#426) to learn about the ClearPoint system's unique real-time MRI guidance capability that enables surgeons to perform a wide range of minimally-invasive neurosurgical procedures.
MDT: 72.60 (+0.55)

MRI Interventions, Inc. Announces 2015 Second Quarter Results
GlobeNewswire - Thu Jul 30, 3:05PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced financial results for the second quarter ended June 30, 2015.

MRI Interventions, Inc. Announces Fiscal 2015 Second Quarter Financial Results Conference Call and Webcast
GlobeNewswire - Fri Jul 24, 8:00AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) invites investors and analysts to participate in management's broadcast review of the Company's 2015 second quarter results.

MRI Interventions ClearPoint(R) Neuro Navigation System Utilized in First Hippocampal Laser Ablation Neurological Procedure at Yale-New Haven Hospital
GlobeNewswire - Mon Jun 08, 7:01AM CDT
MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain, today announced the first stereotactic laser ablation of the hippocampus (SLAH) procedure at Yale-New Haven Hospital. By using the ClearPoint Neuro Navigation System and the Monteris NeuroBlate System in an intra-operative MRI suite, the laser fiber trajectory and target identification was highly accurate, and visible under real time MRI guidance.

MRI Interventions' (MRIC) CEO Frank Grillo on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri May 01, 7:04AM CDT


MRI Interventions Reports 2015 First Quarter Financial Results
GlobeNewswire - Thu Apr 30, 3:00PM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today its financial results for the first quarter ended March 31, 2015.

MRI Interventions to Report First Quarter 2015 Financial Results
GlobeNewswire - Thu Apr 23, 7:32AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) announced today that it will release its first quarter 2015 financial results on Thursday, April 30, 2015, after the close of the U.S. financial markets. MRI Interventions will host a conference call and webcast at 4:30 p.m. Eastern Time that day to discuss the company's results.

Leading neurosurgeons speaking on clinical utility of real-time navigated laser therapy for lesion ablation within Intraoperative MRI Suites at AANS
PR Newswire - Wed Apr 15, 7:25AM CDT
IMRIS, Monteris & MRI Interventions sponsoring luncheon seminar
IMRS: 0.02 (-0.01), IM.TO: 0.72 (-0.02)

MRI Interventions to Exhibit Its ClearPoint Navigation Platform for Neurosurgery at AANS 2015 Annual Meeting
GlobeNewswire - Tue Apr 14, 7:32AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint neuro navigation platform will be on exhibit at the 2015 Annual Meeting of the American Association of Neurological Surgeons (AANS) May 4-6, 2015, in Washington, D.C. Conference attendees are invited to visit the MRI Interventions booth (#708) to learn about the ClearPoint system's unique capability to enable a wide range of neurosurgical procedures under real-time MRI guidance.

Penny Stocks Movers for Medican Enterprises, Advanced Medical Isotope, Radiant Creations Group, CIG Wireless, MRI Interventions, and NuGene
PR Newswire - Wed Mar 25, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Medican Enterprises (OTCMKTS:MDCN), Advanced Medical Isotope (OTCMKTS:ADMD), Radiant Creations Group (OTCBB:RCGP), CIG Wireless (OTCBB:CIGW), MRI Interventions (OTCBB:MRIC), and NuGene (OTCBB:NUGN).

New finance chief at MRI Interventions
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 8:28AM CDT


MRI Interventions' New Chief Financial Officer Harold A. Hurwitz Brings Considerable Medical Device Finance Experience to Growing Company
GlobeNewswire - Tue Mar 17, 7:32AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) is pleased to announce that seasoned medical device financial executive Harold A. (Hal) Hurwitz has been appointed the company's next Chief Financial Officer. Mr. Hurwitz will join the company on March 30, 2015 initially as Vice President, Finance, and he will then assume the CFO position following the filing of the company's quarterly report on Form 10-Q for the first quarter of 2015.
MDT: 72.60 (+0.55)

MRI Interventions' ClearPoint Neuro Navigation System Enables First Brain Biopsy in New GE Intraoperative MRI Scanner at Ohio State University James Cancer Hospital
GlobeNewswire - Tue Mar 10, 7:04AM CDT
MRI Interventions, Inc. (OTCQB:MRIC) today announced that a team led by Dr. Brad Elder, Associate Professor, Neurological Surgery at the Ohio State University (OSU) Wexner Medical Center, has utilized the company's ClearPoint(R) neuro navigation system to enable the first brain biopsy within the OSU Arthur G. James Cancer Hospital's new GE 3-T intraoperative magnetic resonance imaging (MRI) scanner.

MRI Interventions' (MRIC) CEO on Frank Grillo Q4 2014 Results -- Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Mar 05, 8:10PM CST


MRI Interventions Announces $10.2 Million Private Placement
GlobeNewswire - Fri Dec 19, 7:30AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announced it has entered into a definitive securities purchase agreement with a group of investors for the private placement of approximately 15.8 million shares of its common stock and warrants to purchase approximately 6.3 million shares of its common stock.

MRI Interventions Welcomes Seasoned Medical Device Executive Wendelin Maners as Its New Vice President, Marketing
GlobeNewswire - Thu Dec 04, 7:33AM CST
MRI Interventions, Inc. (OTCQB:MRIC) today announces the addition of medical device veteran Wendelin Maners in the role of Vice President, Marketing, as CEO-elect Frank Grillo solidifies his management team. As Vice President, Marketing, Ms. Maners will head all marketing activities and programs, as well as develop and lead internal and external training programs for the Company.
BSX: 16.88 (+0.09), CYBX: 65.44 (+2.29)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 80

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 242

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 559

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 74

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 25

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 343

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Alert: LifeMD Inc Faces Legal Investigation Risks

Updated Category News Views 167

Understanding Recent Developments for LifeMD, Inc. LifeMD, Inc. (NASDAQ: LFMD) is presently facing serious legal scrutiny following an investigation initiated by Faruqi & Faruqi, LLP. This renowned national securities law firm has stepped in to evaluate potential claims on behalf of investors. Investor Engagement Opportunities If you are among the investors who incurred...

Continue Reading
Value Stocks Poised for Growth Amid Market Shifts

Updated Category News Views 119

Value Stocks Set for Growth as Market Dynamics Change The stock market is currently experiencing a notable shift away from tech dominance. In recent months, tech stocks have faced challenges, raising questions about the potential revival of value stocks. This change in market sentiment is particularly evident in the impressive performance of the Value ETF, which has...

Continue Reading
EXEL Industries Reveals Key Share and Voting Rights Insights

Updated Category News Views 57

EXEL Industries Overview EXEL Industries is a prominent French Société Anonyme, with a robust share capital amounting to €16,969,750. The company has established a significant presence in the industry through its high standards and innovative products. Understanding Share Capital and Voting Rights On August 31, 2024, EXEL Industries provided updated insights regarding...

Continue Reading
Protective Life Corporation Strengthens Portfolio with Acquisition

Updated Category News Views 112

Protective Life Corporation Strengthens Its Portfolio In a significant development for Protective Life Corporation, the company has successfully completed the acquisition of ShelterPoint Group, Inc. Shielded under the corporate umbrella of Dai-ichi Life Holdings, Inc., Protective Life Corporation continues to solidify its position in the employee benefits industry. This...

Continue Reading
Safeguarding Your Personal Data in a Digital Health Era

Updated Category News Views 160

Understanding the Importance of Data Security in Health Tech As the holiday season approaches, consumers are excitedly purchasing various digital health tools such as fitness trackers, meditation apps, and smart scales. While these innovations can greatly enhance our wellness journey, they also raise significant concerns regarding the security of our personal data. Expert...

Continue Reading